首页 > 646 jili 777

#jolibetph

2025-01-11
#jolibetph
#jolibetph Israel and Lebanon's Hezbollah agree to a ceasefire after nearly 14 months of fighting JERUSALEM (AP) — Israel has approved a ceasefire agreement with Lebanon’s Hezbollah militants, setting the stage for an end to nearly 14 months of fighting linked to the ongoing war in the Gaza Strip. The ceasefire is set to take hold at 4 a.m. local time on Wednesday. Israeli warplanes have carried out the most intense wave of strikes in Beirut and its southern suburbs since the start of the conflict amid a record number of evacuation warnings. At least 42 people were killed in strikes across Lebanon, according to local authorities. President Joe Biden said his administration now would make a renewed push for a ceasefire in Gaza. What both sides are saying about the ceasefire deal between Israel and Lebanon's Hezbollah A ceasefire deal that could end more than a year of cross-border fighting between Israel and Lebanon’s Hezbollah militant group won backing from Israeli leaders. The truce that is set to take effect early Wednesday raised hopes and renewed difficult questions in a region gripped by conflict. Hezbollah leaders also signaled tentative backing for the U.S.-brokered deal, which offers both sides an off-ramp from hostilities But the deal does little directly to resolve the much deadlier war that has raged in Gaza since Hamas militants attacked southern Israel last October. Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs WASHINGTON (AP) — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound for a large segment of Americans who are obese. But it’s unclear if the proposal, which would not go into effect until after Trump takes office, will have support from his new administration — including from Robert F. Kennedy Jr., an opponent of the drugs who has been tapped by the president-elect to serve as head of HHS. Trump vows tariffs over immigration. What the numbers say about border crossings, drugs and crime. WASHINGTON (AP) — President-elect Donald Trump is threatening tariffs on Mexico and Canada as he seeks to portray them as responsible for illegal immigration and drug smuggling. Over its tenure, the Biden administration has struggled with growing numbers of migrants arriving at the southern border. But this year, the number of people crossing the border without documents has actually been falling. That's due in part to stricter enforcement by Mexican authorities as well as asylum restrictions announced earlier this year by the Biden administration. When it comes to fentanyl smuggling, much of the deadly supply comes from Mexico though statistics show more than 86% of those sentenced for fentanyl trafficking crimes in the 12 months ending September 2023 were U.S. citizens. AP finds that a Pentagon-funded study on extremism in the military relied on old data Early this year, Pete Hegseth told a Fox News audience a new, Pentagon-funded study proved that the number of military service members and veterans involved in the Jan. 6 insurrection did not indicate a wider problem in the armed forces. Hegseth, Donald Trump's pick to head the Department of Defense, wasn’t alone. The Wall Street Journal’s opinion page highlighted the same report as evidence that extremists in military communities were “phantoms” created by a “false media narrative.” The X account for Republicans on the House Armed Services Committee posted that the study showed the focus on extremism in the military was a “witch hunt.” But The Associated Press has found that the study relied on old data, misleading analyses and ignored evidence that pointed to the opposite conclusion. How Trump's bet on voters electing him managed to silence some of his legal woes WASHINGTON (AP) — Special counsel Jack Smith move to abandon two federal cases accusing Trump of endangering American democracy and national security does away with the most serious legal threats Trump was facing as he returns to the White House. It was the culmination of a monthslong defense effort to delay the proceedings at every step and use the criminal allegations to Trump's political advantage, putting the final word in the hands of voters instead of jurors. The move just weeks after Trump’s victory over Vice President Kamala Harris underscores the immense personal stake Trump had in the campaign in which he turned his legal woes into a political rallying cry. Walmart's DEI rollback signals a profound shift in the wake of Trump's election victory NEW YORK (AP) — Walmart’s sweeping rollback of its diversity policies is the strongest indication yet of a profound shift taking hold at U.S. companies that are re-evaluating the legal and political risks associated with bold programs to bolster historically underrepresented groups in business. The changes announced by the world’s biggest retailer on Monday followed a string of legal victories by conservative groups that have filed an onslaught of lawsuits challenging corporate and federal programs aimed at elevating minority and women-owned businesses and employees. The retreat from such programs crystalized with the election of former President Donald Trump, whose administration is certain to make dismantling diversity, equity and inclusion programs a priority. Brazil’s Bolsonaro planned and participated in a 2022 coup plot, unsealed police report alleges SAO PAULO (AP) — Brazil’s former far-right President Jair Bolsonaro was fully aware of and actively participated in a coup plot to remain in office after his defeat in the 2022 election, according to a Federal Police report that has been unsealed. Brazil’s Federal Police last Thursday formally accused Bolsonaro and 36 other people of attempting a coup. They sent their 884-page report to the Supreme Court, which lifted the seal. Bolsonaro called a meeting in December 2022, during which he presented a draft decree to the commanders of the three divisions of the armed forces, that would have declared the vote fraudulent, to justify a possible military intervention. Bolsonaro has repeatedly denied any wrongdoing. New rule allows HIV-positive organ transplants People with HIV who need a kidney or liver transplant will be able to receive an organ from a donor with HIV. That's according to a new rule announced Tuesday by U.S. health officials. Previously, such transplants could be done only as part of research studies. The new rule takes effect Wednesday. It's expected to shorten the wait for organs for all, regardless of HIV status, by increasing the pool of available organs. The practice is supported by a decade of research, during which 500 transplants of kidneys and livers from HIV-positive donors have been done in the U.S. Surveillance tech advances by Biden could aid in Trump's promised crackdown on immigration President-elect Donald Trump will return to power next year with a raft of technological tools at his disposal that would help deliver his campaign promise of cracking down on immigration — among them, surveillance and artificial intelligence technology that the Biden administration already uses to help make crucial decisions in tracking, detaining and ultimately deporting immigrants lacking permanent legal status. One algorithm, for example, ranks immigrants with a “Hurricane Score,” ranging from 1-5, to assess whether someone will “abscond” from the agency’s supervision.

By DAVID BAUDER Time magazine gave Donald Trump something it has never done for a Person of the Year designee: a lengthy fact-check of claims he made in an accompanying interview. Related Articles National Politics | Trump’s lawyers rebuff DA’s idea for upholding his hush money conviction, calling it ‘absurd’ National Politics | Ruling by a conservative Supreme Court could help blue states resist Trump policies National Politics | A nonprofit leader, a social worker: Here are the stories of the people on Biden’s clemency list National Politics | Nancy Pelosi hospitalized after she ‘sustained an injury’ on official trip to Luxembourg National Politics | Veteran Daniel Penny, acquitted in NYC subway chokehold, will join Trump’s suite at football game The fact-check accompanies a transcript of what the president-elect told the newsmagazine’s journalists. Described as a “12 minute read,” it calls into question 15 separate statements that Trump made. It was the second time Trump earned the Time accolade; he also won in 2016, the first year he was elected president. Time editors said it wasn’t a particularly hard choice over other finalists Kamala Harris, Elon Musk, Benjamin Netanyahu and Kate Middleton. Time said Friday that no other Person of the Year has been fact-checked in the near-century that the magazine has annually written about the figure that has had the greatest impact on the news. But it has done the same for past interviews with the likes of Joe Biden, Netanyahu and Trump. Such corrections have been a sticking point for Trump and his team in the past, most notably when ABC News did it during his only debate with Democrat Kamala Harris this fall. There was no immediate response to a request for comment on Friday. In the piece, Time called into question statements Trump made about border security, autism and the size of a crowd at one of his rallies. When the president-elect talked about the “massive” mandate he had received from voters, Time pointed out that former President Barack Obama won more electoral votes the two times he had run for president. The magazine also questioned Trump’s claim that he would do interviews with anyone who asked during the campaign, if he had the time. The candidate rejected a request to speak to CBS’ “60 Minutes,” the magazine said. “In the final months of his campaign, Trump prioritized interviews with podcasts over mainstream media,” reporters Simmone Shah and Leslie Dickstein wrote. David Bauder writes about media for the AP. Follow him at http://x.com/dbauder and https://bsky.app/profile/dbauder.bsky.social.Speaker schedules opposition motions after Tories opt against own non-confidence vote



NoneAs America prepares to transition to a new presidential administration, I want to take stock of the progress we have made together in laying the foundations for an economy that creates opportunity for all Americans. Over the last four years, we’ve faced some of the most challenging economic conditions in our history. Not only have we recovered, we’ve come out stronger, and have laid foundations for a promising new chapter in our American comeback story. It will take years to see the full effects in terms of new jobs and new investments all around the country, but we have planted the seeds that are making this happen. If these investments and actions are built upon, U.S. economic leadership will be stronger and the middle class more secure in the years and decades ahead. When I took office, the economy wasn’t working for most Americans. It was clear that a fundamentally new playbook was essential. My focus was to transform the economy to improve the lives of regular Americans, the kinds of people I grew up with. That’s why I fought to invest in the jobs of the future, lower costs, raise wages, and strengthen workers and small businesses—because I know this will help American families and build the economy from the middle out and bottom up. At that time, economic policy was in the grip of a failed approach called trickle-down economics. Trickle-down tried to grow the economy from the top down. It slashed taxes for the wealthy and large corporations and tried to get government “out of the way,” instead of delivering for working people, investing in infrastructure, and ensuring America stays at the leading edge of innovation. But this approach failed. Too many Americans saw an economy that was stacked against them with failing infrastructure, communities that had been hollowed out, manufacturing jobs that were offshored to China, prescription drugs that cost than in any other developed country, and workers who had been left behind. I believe that, from America’s earliest days, we have been at our best when we have taken on important challenges and fought to deliver big things on behalf of the American people—from the Erie Canal to the transcontinental railroad, from the Hoover Dam to rural electrification, from the Social Security system to the National Highway System. As president, I fought to write a new economic playbook that builds the economy from the middle out and bottom up, not the top down. I fought to make smart investments in America’s future that put us in the lead globally. I fought to create good jobs that give working families and the middle class a fair shot and the chance to get ahead. I fought to lower costs for consumers and give smaller businesses a fair chance to compete. In what follows, I describe why this new approach is so important. I have always seen the economy from the perspective of the small city where I grew up—a city with a proud history of making things in America, a city that fell on hard times when politicians turned their backs on communities like mine. Too many corporations moved their supply chains overseas and focused on quarterly profits and share buybacks instead of investing in their workers and communities here at home. Our fell further and further behind, and a flood of cheap, subsidized imports from China and other countries our factory towns. Economic opportunity and innovation became more and more in a few major cities, while heartland communities were left behind. Scientific discoveries and inventions developed in America were in countries abroad, bolstering their manufacturing instead of ours. I came to office with a different vision. When I said I was president of all America, I meant it. I was determined we would invest in the places that have suffered from neglect and disinvestment: rural areas, manufacturing towns, coal and power plant communities, in red states and blue states. I was determined to create good jobs with family-sustaining wages that don’t require a four-year college degree. I vowed to restore U.S. leadership in the industries of the future—like semiconductors and clean energy—while fortifying our infrastructure and supply chains. I committed to putting the United States back in a position of clean-energy leadership and building a 100 percent clean power grid. We succeeded in securing historic investment laws to turn those goals into reality. My Investing in America Agenda—the Bipartisan Infrastructure Law (BIL), the CHIPS and Science Act, and the Inflation Reduction Act (IRA)—together mark the most in the United States since the New Deal. For many years, this country’s infrastructure was underresourced and neglected. Since the passage of the BIL, we have been hard at work expanding high-speed internet, replacing pipes to provide clean drinking water in every community, and rebuilding roads and bridges and ports and airports . These projects are creating millions of good jobs—many of them unionized—so American families across America will share in the benefits of the infrastructure investments. In the years since I took office, we’ve funded over infrastructure and clean-energy projects in every state and territory in the country. The has hit record highs. Already, tens of thousands of skilled construction workers are hard at work building the factories of the future. Soon, these factories will be hiring advanced manufacturing workers, and products from semiconductors to batteries to electric vehicles will be rolling off of these new, American production lines. The Inflation Reduction Act is the single investment in clean energy in the history of the world. It is creating good-paying jobs and investing in American manufacturing, while also taking action to reduce emissions. It is spurring investments to build solar panels in ; to build wind towers in ; and to manufacture and recycle batteries in . Our place-based investment approach is creating economic opportunity in communities across the country that had been . Our investments in high-speed internet and transportation networks are reconnecting these communities to jobs and revitalizing small businesses. We are investing in technology and innovation engines in every region of the country that will sustain economic development for years to come. We are supporting farmers that use climate-smart agriculture practices and ensuring rural small businesses can access historic development resources that will cut energy costs and increase energy efficiency. Communities across the country are poised for economic comebacks. With the benefit of our special investment incentives, the places hit hardest by and by are receiving a disproportionate share of new investment, bringing hope to communities that have been . For instance, the first in 40 years will be built in Kentucky, powered entirely by clean energy. We have taken on behalf of American workers, businesses, and factory towns to counter violations of our trade laws. China is using unfair practices to flood global markets with underpriced goods in sectors like vehicles and solar cells and wafers. That’s why we imposed tariffs on imports from China in key sectors. A on Chinese electric vehicles, for instance, is enabling American auto communities to continue powering the global car industry. But tariffs by themselves are no panacea. To regain and sustain America’s lead in areas from clean energy to semiconductors, it is vital to couple targeted tariffs with strong investments in manufacturing, R&D, and workforce. While semiconductors were invented in America, for too many years politicians in Washington gave up on the semiconductor industry, and leading-edge semiconductor manufacturing moved to Asia. But thanks to the CHIPS and Science Act, some of the most advanced semiconductors in the world will be built in ; ; ; and . Before the CHIPS and Science Act, of the world’s leading-edge chips were manufactured in Taiwan. Some skeptics said America could never compete. They were wrong. With the benefit of a CHIPS award, not only has global leader TSMC committed to build three - manufacturing plants in Arizona, but in October it was early production yields at one of those plants met those at manufacturing plants in Taiwan. And America will be the only economy in the world to have all five of the most advanced semiconductor manufacturers in the world operating on its shores—no other economy has more than two. My investment agenda is already attracting in commitments of private capital so far, not crowding it out. These investments are helping to strengthen our supply chains, so that we won’t be dependent on a single foreign country for the semiconductors, pharmaceuticals, or critical minerals that we need. And they are starting to create opportunities for workers, businesses, and communities to contribute to the economy in the world. This is my vision—a future that is made by American workers across America. It will take years to see the full effects in terms of new jobs and new investments all around the country, but we have laid strong foundations, and now it is important to build on and not reverse the progress we have made. I’ve long seen the economy through the eyes of my dad, who used to say, “A job is a lot more than a paycheck. It’s about your dignity. It’s about your place in the community.” But trickle-down economics ignored this basic truth. Tax cuts for the wealthy create opportunities for workers and their families. Instead, factory towns were hollowed out, and fewer Americans ended up than their parents. My middle-out/bottom-up economic playbook instead puts working families and the middle class at the center of all of my economic policies. When I took office, the economy was in chaos. of businesses were shut down, and of Americans were out of a job. As soon as I came to office, I signed the American Rescue Plan that vaccinated the nation and got our economy going again. As a result, America returned to full employment than other advanced economies, and has seen the lowest average of any administration in 50 years. The share of working-age Americans who are employed is at a multi-decade high, at over . We’ve also seen record lows in unemployment for workers who have often been previous recoveries. In our full-employment expansion, the real pay of low-wage workers that of higher-paid workers, the reverse of what we saw under trickle-down. The pandemic and the inflation it created caused enormous pain and hardship for families across America. That’s true not just for us but for every major economy in the world. But now, inflation has come down in the United States— than almost any of the world’s other advanced economies. I know how important it is to provide pathways to middle-class careers for the who choose not to pursue a four-year college degree. The many investments I described above have provided an unprecedented opportunity to create good jobs in construction and manufacturing. We created in areas with new investments to align high schools, community colleges, unions, businesses, and local governments around stackable credentials that enable students to move seamlessly from the classroom to careers, and allow workers to upskill and secure better jobs. To build the pipeline of skilled and trained workers for the industries of the future, we’ve also invested in registered apprenticeships and career technical education programs than any previous administration, with hired during my time in office. Many of these apprenticeship programs are sponsored by unions, which means that graduates will earn a good union wage with benefits and retirement. The middle-out/bottom-up playbook supports unions because unions have been vital to building the middle class by providing pathways to family-sustaining careers. When I came to office, union workers and retirees faced cuts of or more to their earned benefits through no fault of their own. But we fought for and secured the Butch Lewis Act to restore and protect the pension benefits they earned. Because of this law, we have protected the pensions of union workers and retirees so far. Expanding unionization is essential to creating a fairer economy. The evidence is clear: Unions are the best way for American workers to get their fair share. I was proud to be the president to walk a picket line with workers. I appointed members to the National Labor Relations Board to enforce our labor laws rather than undermine them, as happened under the previous administration. It is no accident that union election petitions have since I took office. Support for unions is the it’s been in more than half a century, and the labor movement is expanding to new companies and industries. The middle-out/bottom-up playbook is not just about giving working families a fair shot, it is also about asking the very wealthy and most profitable corporations to pay their fair share. We need to balance our tax system to work in favor of the middle class and working families, not the rich and well-connected. Tax fairness is central to building an economy that works for all Americans—where growth is broadly shared and we keep our commitments to seniors and have the resources to meet key national needs over the long run. I promised not to raise taxes on middle-class families, and I kept my promise. Instead, I delivered tax cuts to help families raise children and afford health care. I fought hard to expand the Child Tax Credit because it is one of the investments we can make, cutting child poverty nearly in in 2021. I also secured an expansion of the premium tax credits to make health insurance more affordable for millions of Americans, which helped lift health insurance coverage to levels and doubled Black and Hispanic enrollment, with over people enrolled. I also secured investments to make sure wealthy taxpayers pay what they owe and play by the same rules. After a decade of severe underfunding, I fought hard to secure an investment in modernizing the IRS that is already paying off. The IRS is already collecting over a from wealthy tax cheats. It has successfully rolled out Direct File, offering millions of Americans a free and easy way to file their taxes for the first time. I’ve also long seen the economy from the perspective of my family’s kitchen table growing up, so I know that the high prices from the pandemic have been hard on American consumers. That’s why I have been laser-focused on lowering costs for hardworking Americans. Our work to help unsnarl supply chains helped bring inflation back down to the levels right before the pandemic. But even with pandemic inflation back down, many consumer prices are too high. In some sectors of the economy, high prices reflect inadequate competition. And too often, politicians in Washington haven’t had the courage to take on big corporate interests when they use their market power to mark up their prices. Promoting competition is central to my vision for an American economy that grows from the bottom up and the middle out. I came to office determined to make promoting competition a priority for every agency. Fair competition means better choices, a fair shot for small businesses, a more resilient economy, and lower prices. This is particularly important in health care. It’s not right that Americans more to buy a prescription drug in Chicago than it costs elsewhere in the world. I am proud that I took on the pricing power of Big Pharma and secured major cost savings in the Inflation Reduction Act. Due to the IRA, people with Medicare pay no more than $35 a month for insulin, down from as much as $400. Out-of-pocket drug costs for people with Medicare will be capped at $2,000 starting next year. But seniors are already saving on lower prescription drug costs thanks to the IRA. In just the first six months of 2024, seniors got $1 billion back in their pockets with additional savings in the years ahead thanks to this historic legislation. Starting in 2026, prices will be reduced by on key drugs for people with Medicare, and taxpayers will save roughly $160 billion over a decade. We also worked to lower gas prices. After Russia’s war against Ukraine caused gas prices to spike globally, I undertook the biggest of oil from the Strategic Petroleum Reserve in history. I also encouraged oil and gas companies to take their record profits and invest in more production. Today, American energy production is at —including record oil and gas production—and the price of a gallon of gas is below the level before the time of the invasion. In addition, we have successfully replenished all of our reserves while making taxpayers a profit . By , we lowered costs for families while securing a good deal for U.S. taxpayers. Fair competition is especially important for small businesses, which need a level playing field to have a fair shot to compete and win. Our competition and investment policies are unleashing a wave of new business startups on Main Streets in towns and cities across the country. In fact, we have seen new business applications during this administration—the three strongest years on record. Black and Hispanic entrepreneurs have been leaders of this small-business boom, with Black business ownership and Hispanic business ownership since before the pandemic. The share of women business owners is also on the . The bottom line is, the past four years have been marked by some of the toughest economic challenges in American history. We took decisive action and it paid off, with the strongest economic comeback in the world. Even while managing that recovery, we made generational investments in our economy and balanced the scales more toward workers and the middle class. Outside have noted that due to our policies, “President-elect Trump is receiving the strongest economy in modern history which is the envy of the world.” It is worth reviewing the facts on the U.S. economy that I am handing off to my successor: Unemployment has been at the lowest average rate of any administration in 50 years. We have created over 16 million new jobs, and more than 1.5 million of those are in manufacturing and construction. Inflation has been brought down close to 2 percent, the same level as right before the pandemic. Incomes are up adjusted for inflation, and unions have won wage increases in industries like autos, ports, aerospace, and trucking. We’ve seen 20 million applications to start small businesses. Our economy has grown 3 percent per year on average the last four years— than any other advanced economy. Domestic energy production is at a record high, and gas prices are around $3 per gallon. When I came to office, I believed the only way for a president to lead America was to lead of America. In fact, the historic investments I made went more to red states than blue states. I believe that the economy as I leave is stronger for Americans. And I believe there is no country on Earth better positioned to lead the world in the years to come than America today. Now we are at an inflection point. The next four years will determine whether the incoming administration builds on this strength. If it does, then 10 or even 50 years from now, U.S. economic leadership will be even stronger than it is today—proving that when the middle class does well, we all do well.

ATLANTA — To improve Georgia’s troubled prison system, the General Assembly should hike correctional officer salaries, consider more private-public partnerships to expand capacity, increase mental health services and move to single-person cells to improve safety. Those are among a slate of recommendations that a state Senate study committee approved Friday, following hours of testimony at a series of meetings that began in August. Other recommendations that won approval include asking for an audit of contracts to identify any excessive vendor costs, ordering a compensation study, prioritizing new technology to improve security at current and new facilities, and taking action to make sure wardens adhere to consistent policies to prevent culture differences among facilities. The committee also recommended that the state seek federal approval to jam cellphone signals at prisons. Prisoners have used cellphones to run criminal enterprises from inside the prisons, including directing drug trafficking networks and operating various fraud schemes. But the committee voted against a recommendation to create an independent oversight department or bureau to monitor the state prison’s system. “Oversight is provided by regular committees, subcommittees and study committees, and I’m not sure we need to create yet another level,” said GOP Sen. John Albers in opposing the recommendation. The study committee chairman, GOP Sen. Randy Robertson also opposed the idea, saying he doesn’t favor an ombudsman process that doesn’t answer to anyone. “I think a part of oversight is what we’re doing right now,” he said. The study committee, created by the Senate in March , reached its recommendation after hearing more testimony Friday morning, primarily from advocates, people whose loved ones had died in custody, and people who had served sentences in Georgia. Most of the previous meetings focused on testimony from the Georgia Department of Corrections. Friday’s testimony included stories of rampant violence, deaths and inadequate health care experienced by those in prison. Suspicious deaths that weren’t properly investigated were also mentioned during the meeting. That included the testimony of Heather Hunt, whose son died at Rogers State Prison in September. She was told the death was a suicide, but she said prison officials were hostile to her questions and delayed providing information that didn’t add up when it was provided. In the wake of hearing the morning testimony, GOP Sen. Timothy Bearden suggested that the Georgia Bureau of Investigation should be brought in to investigate all deaths within Georgia’s prisons. Now, the GBI handles autopsies, but the GDC’s internal investigators handle most of the death investigations. Robertson said it’s generally up to GDC Commissioner Tyrone Oliver to decide whether to call in the GBI. Robertson said it might make sense to routinely rely on the GBI, although the committee did not plan to include the suggestion in its report. “One thing that it does is it takes the suspicion out of the mix and the conspiracy theories tend to go away when that happens,” Robertson said. Homicides within the Georgia prison system have reached record levels this year, the AJC has found. The General Assembly will take up the recommendations when it convenes in January. The Georgia General Assembly has faced increasing scrutiny in recent months in the wake of an AJC investigation , a blistering report issued in October by the U.S. Department of Justice and a highly critical contempt order issued in April by a federal judge in a long-running civil case . Gov. Brian Kemp announced in June that he had hired consultants to conduct a deep study of the prison system and recommend changes to improve conditions. The Georgia Department of Corrections has said it is making progress toward addressing problems within the prison system. ©2024 The Atlanta Journal-Constitution. Visit at ajc.com . Distributed by Tribune Content Agency, LLC.Food photography has never been more popular — all you have to do is open TikTok or Instagram and you’ll be flooded with an array of recipe videos and stunning photographs of culinary creations. In a bid to elevate the art of food photography, FujiFilmAustralia has launched an exciting new experience for Sydneysiders — Foodtography Tours. Designed to help food lovers and content creators level up their social media game, the exclusive tours will run until November 30 with tickets available from $60. Know the news with the 7NEWS app: Download today They offer a unique opportunity to explore some of Sydney’s hottest culinary spots while learning the ins and outs of capturing the perfect food shot. The initiative comes on the heels of new research conducted by FujiFilm revealing that 32 per cent of young Aussies struggle to snap good food photos, with many admitting they lacked the right tools or skills to do justice to their meals. The Foodtography Tours have been developed in collaboration with Local Sauce Tours, one of Australia’s leading culinary tour operators, and TikTok sensation Adrian Widjonarko (aka Adrian Widjy). The tours will give participants a chance to taste their way through Sydney’s Newtown neighbourhood. Some of the delicious treats, you’ll get to try include Turkish ice cream, Italian fritti, modern Cantonese dishes and Mexican street food, and even a twist on the classic Aussie meat pie — all while Fujifilm’s expert photographers share tips and tricks to get that picture-perfect shot. The tours are a perfect introduction to FujiFilm’s latest innovation, the X-M5 mirrorless digital camera, launched in October as the brand’s first camera aimed squarely at the creator generation. The X-M5 boasts a lightweight, compact design, superior image quality, and a 9:16 recording mode ideal for creating engaging content. It’s a camera that allows content creators, whether beginners or experienced, to snap vibrant photos and videos with ease, perfect for everything from food shots to vlogs. “At FujiFilm we are passionate about inspiring creativity, and we know that food photography has become a beloved genre for many Australians,” general manager of the Electronic Imaging & Optical Devices Division at FujiFilm Australia Shaun Mah explains. “With the launch of the X-M5, we saw an opportunity to bring together the worlds of food, photography, and technology.” Throughout the Foodtography Tours, guests will be guided by Adrian Widjonarko, a renowned food content creator who has become a household name thanks to his TikTok presence. Widjonarko, who has been documenting Sydney’s must-try food spots for over four years, is excited to share his knowledge with participants and show them how to bring their food photography skills to the next level. “It’s been an incredible journey capturing and sharing Sydney’s food scene, and I’m thrilled to work with FujiFilm and Local Sauce Tours to help others do the same,” Adrian says. Whether you’re a food lover looking to capture the perfect shot, or an aspiring content creator ready to take your social media presence to the next level, these tours promise to offer a deliciously creative experience you won’t want to miss. The tours also make a perfect early Christmas present for any foodies in your life. To book, head over to Local Sauce Tours website here for more information and to secure a place on one of the exclusive tours.

Pakistan’s first AI-enhanced virtual internship launched KARACHI: 10Pearls has launched 10Pearls Shine, Pakistan’s first fully remote, AI-powered internship programme for a period of eight weeks with a multi-tiered curriculum encompassing both technical and soft skills. 10Pearls’ unique internship offers students the chance to learn in-demand technical and leadership skills from anywhere within the country, preparing them with a strong foundation for a future career in technology. Students are assigned dedicated technical mentors who guide them through hands-on projects based on their chosen domain. The virtual edition received an overwhelming response, with over 10,000 students registering. Through a rigorous selection process, 100 top-tier students were chosen across two dynamic cohorts, empowering them to grow and excel in the tech industry. Drawing participants from top universities, including LUMS, IBA and FAST, the event brings together the country’s brightest minds.

FREIBURG, Germany (AP) — Freiburg survived a late comeback to beat Wolfsburg 3-2 and move into fifth place in the Bundesliga on Friday. The sides started the day equal on points and Wolfsburg had won its last five games in the league and cup. But Lukas Kübler scored an opportunist opener three minutes before the break and added a second with his head six minutes into the second half to put Freiburg in the driving seat. Michael Gregoritsch added the third in the 62nd. Jonas Wind came off the bench to score his third goal in two games and Mattias Svanberg cut the deficit seven minutes from time as Wolfsburg desperately looked for a way into the game. But it was too late, and Freiburg moved above Wolfsburg to fifth place on the table and equal on points with Leipzig, which has a game in hand. The match was an important one for two teams vying for a Champions League place next year. Although Bayern Munich have a six-point advantage over second-placed Eintracht Frankfurt, only eight points separate the next nine clubs. AP soccer: https://apnews.com/hub/soccerThere are some things you just don't do in certain parts of the US. You don't use inferior salsa during a cattle drive in Texas. You don't eat pizza with a knife and fork in New York City. You don't yell "Belichick is a big, fat cheater!" in a crowded Boston bar (even if it happens to be true). And if you're in New Jersey or just America in general, you NEVER take the holy name of Bruce Springsteen in vain in ANY manner. So it's bewildering why one New Jersey representative would even think about faking his listening habits when it comes to The Boss. 9to5Mac spotted a curious looking post on X from US Rep. Josh Gottheimer (D-NJ). The congressman shared what appeared to be his Spotify Wrapped playlist for the year, with one list consisting of Springsteen's classic tracks like "Glory Days" and "Thunder Road" and the other filled with tracks from various hip hop stars. He tried to cement his... Danny GallagherFreiburg survives late onslaught to beat Wolfsburg in Bundesliga thriller

SAN DIEGO , Dec. 13, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved CRENESSITYTM (crinecerfont) capsules and oral solution as an adjunctive treatment to glucocorticoid replacement to control androgens in adult and pediatric patients four years of age and older with classic congenital adrenal hyperplasia (CAH), a rare, serious and lifelong genetic condition involving the adrenal glands. CRENESSITY, a potent and selective oral corticotropin-releasing factor type 1 receptor (CRF 1 ) antagonist, is the first and only classic CAH treatment that directly reduces excess adrenocorticotropic hormone (ACTH) and downstream adrenal androgen production, allowing for glucocorticoid dose reduction. It is a breakthrough in the treatment landscape for classic CAH. "For the last three decades, Neurocrine Biosciences, together with our late founder, Wylie W. Vale , has conducted groundbreaking research uncovering the critical role of corticotropin-releasing factor and its receptor, CRF 1 , in the pathophysiology of congenital adrenal hyperplasia," said Kyle W. Gano , Ph.D., Chief Executive Officer, Neurocrine Biosciences. "The approval of CRENESSITY is a significant milestone for the CAH community, and we are grateful to the individuals who participated in our clinical trials, including their families and caregivers, and to the clinical investigators who helped advance a new therapy and class of medicines." "Patients and families struggle to achieve balance between managing the symptoms of CAH and the side effects or complications of treatment with high-dose steroids, which may impact quality of life," said Dina Matos , Executive Director, CARES Foundation. "We are grateful to Neurocrine Biosciences for engaging with our community throughout the drug development process to understand our needs and ultimately providing this new medication that can help reduce excess adrenal androgens and the need for high-dose steroid treatment for individuals living with CAH." CRENESSITY is expected to be commercially available in approximately one week. The medication will be provided through PANTHERx Rare, a specialty pharmacy, to centralize and simplify CRENESSITY prescription fulfillment. Neurocrine Biosciences is committed to supporting patients in obtaining treatment with CRENESSITY by offering Neurocrine Access Support, a free, comprehensive assistance program created for patients, caregivers and healthcare providers. It offers a range of options to make sure patients have everything they need to begin and continue taking CRENESSITY. A dedicated Care Coordinator, backed by a team, is available to help patients and caregivers navigate the insurance process and identify appropriate financial assistance options. Most patients will pay $10 or less per month for CRENESSITY*. For more information, visit www.NBIaccess.com/crenessity or call 1-855-CRNSITY (276-7489) Monday-Friday 8 am-8 pm ET . *Additional terms and conditions apply. CAHtalyst TM Clinical Program Overview: The FDA approval is supported by the largest-ever clinical trial program of classic CAH, the CAHtalyst Pediatric and Adult Phase 3 global registrational studies. CAHtalyst Phase 3 data results in pediatric and adult patients with classic CAH were published in The New England Journal of Medicine . "The clinical results across both CAHtalyst studies support the efficacy and safety profile of CRENESSITY and its ability to reduce the overproduction of adrenal androgens, allowing for a meaningful reduction in glucocorticoid dosage, while maintaining or enhancing control of these androgens," said Richard Auchus , M.D., Ph.D., Professor, University of Michigan Health, Principal Investigator. "Chronic treatment with supraphysiologic glucocorticoids can cause a number of short- and long-term health consequences, such as obesity, hypertension and osteoporosis, so the ability for patients with CAH to lower their glucocorticoid dose to a more physiologic level can have profound benefits." In both CAHtalyst studies, CRENESSITY enabled lower steroid doses and decreased androgen levels. Phase 3 CAHtalyst Pediatric Study: Phase 3 CAHtalyst Adult Study: CRENESSITY was well tolerated with few treatment-related adverse events in both CAHtalyst studies. Pediatric and adult patients taking CRENESSITY had no treatment-related serious adverse events. Adrenal insufficiency and crisis are risks of living with CAH that CRENESSITY does not address and can occur when a patient's GC dose is too low. In the CAHtalyst Pediatric study, there were no cases of adrenal crisis among patients taking CRENESSITY or placebo. In the CAHtalyst Adult study, two patients (1.6%) taking CRENESSITY experienced adrenal crisis. No patients on placebo experienced adrenal crisis. However, one patient (1.7%) on placebo experienced adrenal insufficiency. Patients should work with their healthcare provider to manage GC dosing while taking CRENESSITY. For more information about CRENESSITY, visit Crenessity.com . About Congenital Adrenal Hyperplasia Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones, such as cortisol, aldosterone and adrenal androgens, which are essential for life. Approximately 95% of CAH cases are caused by variants of the CYP21A2 gene that leads to deficiency of the enzyme 21-hydroxylase (21-OH). Severe deficiency of this enzyme leads to an inability of the adrenal glands to produce enough cortisol and, in approximately 75% of cases, aldosterone. Because individuals with CAH are still able to produce androgens, the unused precursors that would normally be used to make cortisol instead result in the production of excess amounts of androgens. If left untreated, CAH can result in salt wasting, dehydration and even death. Historically, exogenous glucocorticoids (GCs) have been used not only to correct the endogenous cortisol deficiency, but doses used are higher than cortisol replacement needed (supraphysiologic) to lower the levels of adrenocorticotropic hormone (ACTH) and adrenal androgens. However, GC treatment at high doses has been associated with serious and significant complications of steroid excess, including metabolic issues such as weight gain and diabetes, cardiovascular disease and osteoporosis. Additionally, long-term treatment with high-dose GCs may have psychological and cognitive impact, such as changes in mood and memory. Adrenal androgen excess has been associated with abnormal bone growth and development in pediatric patients, female health problems such as excess facial hair growth and menstrual irregularities, testicular rest tumors in males and fertility issues in both sexes. About The CAHtalystTM Studies The Phase 3 CAHtalystTM global registrational studies were designed to evaluate the safety, efficacy and tolerability of CRENESSITY in children and adults with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The CAHtalyst studies were the largest-ever clinical trial program in classic CAH, including 285 pediatric and adult patients. The CAHtalyst Pediatric study included 103 pediatric patients aged four to 17 years. The study tested two questions. The first question evaluated whether four weeks of CRENESSITY treatment could improve androgen control. The second question evaluated whether an additional 24 weeks of CRENESSITY treatment enabled customized glucocorticoid (GC) down-titration while androstenedione levels were maintained or improved. The CAHtalyst Adult study included 182 adult patients aged 18 to 58 years. Similarly, the first question of the study evaluated whether four weeks of CRENESSITY treatment could improve androgen control, and the second question evaluated whether an additional 20 weeks of CRENESSITY treatment enabled GC reduction to physiologic range while androstenedione levels were maintained or improved. Data from the CAHtalyst Phase 3 studies supported approval of CRENESSITY by the U.S. Food and Drug Administration in December 2024. The open-label extension treatment portions of both studies are ongoing. About CRENESSITYTM (crinecerfont) CRENESSITYTM is a potent and selective, oral corticotropin-releasing factor type 1 receptor (CRF 1 ) antagonist developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens through a non-glucocorticoid (GC) mechanism for the treatment of classic congenital adrenal hyperplasia (CAH). Antagonism of CRF 1 receptors in the pituitary has been shown to decrease ACTH levels, which in turn decreases the production of adrenal androgens and potentially the symptoms associated with CAH. The robust clinical study data demonstrate that lowering adrenal androgen levels with CRENESSITY enables lower, more physiologic dosing of GCs to replace missing cortisol. CRENESSITY comes in capsules and an oral solution. The capsule formulation is available in 50 mg and 100 mg doses. The oral solution is available as a 50 mg/mL strength formulation. For adults 18 years and older, the recommended dosage is 100 mg twice daily taken orally with a meal. For pediatric patients four to 17 years of age weighing less than 55 kg (121 lbs), the recommended dosage is based on body weight and is administered twice daily, taken orally with a meal. For pediatric patients weighing more than 55 kg (121 lbs), the recommended dosage is 100 mg twice daily taken orally with a meal. Healthcare providers can work with patients to determine the appropriate formulation for use depending on patient needs. Patients receiving CRENESSITY should continue GC therapy for cortisol replacement. Important Information Approved Uses CRENESSITY (crinecerfont) is a prescription medicine used together with glucocorticoids (steroids) to control androgen (testosterone-like hormone) levels in adults and children 4 years of age and older with classic congenital adrenal hyperplasia (CAH). IMPORTANT SAFETY INFORMATION Do not take CRENESSITY if you: Are allergic to crinecerfont, or any of the ingredients in CRENESSITY. CRENESSITY may cause serious side effects, including : Allergic Reactions. Symptoms of an allergic reaction include tightness of the throat, trouble breathing or swallowing, swelling of the lips, tongue, or face, and rash. If you have an allergic reaction to CRENESSITY, get emergency medical help right away and stop taking CRENESSITY. Risk of Sudden Adrenal Insufficiency or Adrenal Crisis With Too Little Glucocorticoid (Steroid) Medicine. Sudden adrenal insufficiency or adrenal crisis can happen in people with congenital adrenal hyperplasia who are not taking enough glucocorticoid (steroid) medicine. You should continue taking your glucocorticoid (steroid) medicine during treatment with CRENESSITY. Certain conditions such as infection, severe injury, or shock may increase your risk for sudden adrenal insufficiency or adrenal crisis. Tell your healthcare provider if you get a severe injury, infection, illness, or have planned surgery during treatment. Your healthcare provider may need to change your dose of glucocorticoid (steroid) medicine. Before taking CRENESSITY, tell your healthcare provider about all of your medical conditions, including if you are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Tell your healthcare provider about all the medicines you take , including prescription and over-the counter medicines, vitamins, and herbal supplements. The most common side effects of CRENESSITY in adults include tiredness, headache, dizziness, joint pain, back pain, decreased appetite, and muscle pain. The most common side effects of CRENESSITY in children include headache, stomach pain, tiredness, nasal congestion, and nose bleeds. These are not all the possible side effects of CRENESSITY. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088. Dosage Forms and Strengths: CRENESSITY is available in 50 mg and 100 mg capsules and as an oral solution of 50 mg/mL. Please see full Prescribing Information About Neurocrine Biosciences, Inc. Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com , and follow the company on LinkedIn , X (formerly Twitter) and Facebook . (*in collaboration with AbbVie) The NEUROCRINE BIOSCIENCES Logo Lockup and YOU DESERVE BRAVE SCIENCE are registered trademarks of Neurocrine Biosciences, Inc. CRENESSITY and CAHtalyst are trademarks of Neurocrine Biosciences, Inc. Forward-Looking Statements In addition to historical facts, this press release contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements regarding the potential benefits to be derived from CRENESSITY for the treatment of classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency; the value and benefits CRENESSITY brings to patients with CAH; the ability of Neurocrine Biosciences to ensure patients have access to CRENESSITY; and whether the results from our clinical trials of CRENESSITY are indicative of real-world results. Factors that could cause actual results to differ materially from those stated or implied in the forward-looking statements include, but are not limited to, the following: risks and uncertainties associated with Neurocrine Biosciences' business and finances in general, as well as risks and uncertainties associated with the commercialization of CRENESSITY; whether CRENESSITY receives adequate reimbursement from third-party payors; the degree and pace of market uptake of CRENESSITY; risks and uncertainties relating to competitive products and technological changes that may limit demand for CRENESSITY; risks associated with the Company's dependence on third parties for development and manufacturing activities related to CRENESSITY, and the ability of the Company to manage these third parties; risks that additional regulatory submissions for CRENESSITY or other product candidates may not occur or be submitted in a timely manner; risks that the FDA or other regulatory authorities may make adverse decisions regarding CRENESSITY; risks that post-approval CRENESSITY commitments or requirements may be delayed; risks that CRENESSITY may be precluded from commercialization by the proprietary or regulatory rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; risks and uncertainties relating to competitive products and technological changes that may limit demand for CRENESSITY; and other risks described in the Company's periodic reports filed with the Securities and Exchange Commission, including without limitation the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2024 . Neurocrine Biosciences disclaims any obligation to update the statements contained in this press release after the date hereof other than required by law. © 2024 Neurocrine Biosciences, Inc. All Rights Reserved. CP-CFT-US-0070 12/2024 View original content to download multimedia: https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-fda-approval-of-crenessity-crinecerfont-a-first-in-class-treatment-for-children-and-adults-with-classic-congenital-adrenal-hyperplasia-302331772.html SOURCE Neurocrine Biosciences, Inc. Best trending stories from the week. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. You may occasionally receive promotions exclusive discounted subscription offers from the Roswell Daily Record. Feel free to cancel any time via the unsubscribe link in the newsletter you received. You can also control your newsletter options via your user dashboard by signing in.Pro Football Hall of Famer Randy Moss reveals cancer diagnosis, 6-hour surgery Pro Football Hall of Fame wide receiver Randy Moss says he is being treated for cancer and is recovering from major surgery. In an appearance on Instagram Live on Friday, Moss introduced himself as a cancer survivor and thanked his “prayer warriors” for their support. Moss says a cancerous mass was found in his bile duct, between his pancreas and liver. He says he had surgery to put a stent in his liver on Thanksgiving and then underwent a 6-hour procedure about a week ago to remove the cancer. He says he was hospitalized for six days and released on Friday. De'Vondre Campbell won't be part of the 49ers after his refusal to enter a game, Kyle Shanahan says SANTA CLARA, Calif. (AP) — San Francisco coach Kyle Shanahan said linebacker De’Vondre Campbell won’t be part of the 49ers moving forward after he refused to enter a game after losing his starting job. Shanahan said the team is still working through the options of how to deal with Campbell after he walked to the locker room in the middle of a 12-6 loss to the Los Angeles Rams. Shanahan says the team is weighing its options, which could include a suspension or release, but that Campbell won't be part of the team for the final three weeks of the season. Trae Young, Hawks hoping to win big in Vegas at the NBA Cup semifinals LAS VEGAS (AP) — Trae Young might be the NBA’s biggest enigma. Young’s fans can point to numbers and say he’s an elite player. His detractors can point to numbers and say he’s overrated. Both arguments have validity. To some, his cocky ways are endearing. To others, they’re infuriating. This can’t be argued: He’s helping Atlanta author one of the season’s surprise stories. The Hawks are in the NBA Cup semifinals, set to play Milwaukee on Saturday before the other semifinal between Oklahoma City and Houston. The title game is Tuesday night. Analysis: Only LeBron James knows what's happening right now, and what's in his future LAS VEGAS (AP) — LeBron James was starring in Las Vegas at this time last year, the headline attraction while he and the Los Angeles Lakers were about to win the inaugural version of the event now known as the NBA Cup. That's not the case this year. “Personal reasons ... he’s taking some time” is what Lakers coach JJ Redick said this week when detailing why James was missing from practice. “Left foot soreness” is the reason why the Lakers have ruled him out of Friday’s game in Minnesota. There’s been trade speculation in recent days. It's all very different than a year ago at Cup time. Yankees get closer Devin Williams from Brewers for Nestor Cortes, Caleb Durbin NEW YORK (AP) — The New York Yankees have acquired All-Star closer Devin Williams from the Milwaukee Brewers for left-hander Nestor Cortes and infield prospect Caleb Durbin. The Yankees also will send $2 million to the Brewers as part of the trade. A 30-year-old right-hander, Williams and his signature “Airbender” changeup are eligible for free agency after the 2025 season. He was diagnosed during spring training with two stress fractures in his back and didn’t make his season debut until July 28. Williams was 14 for 15 in save chances with a 1.25 ERA, striking out 38 and walking 11 in 21 2/3 innings. Cubs acquire All-Star outfielder Kyle Tucker in trade with the Astros CHICAGO (AP) — The Chicago Cubs have acquired All-Star outfielder Kyle Tucker in a trade with the Houston Astros, paying a big price for one of baseball’s best hitters. The Cubs sent third baseman Isaac Paredes, right-hander Hayden Wesneski and Cam Smith, one of their top infield prospects, to the Astros for Tucker, who is eligible for free agency after the 2025 season. Tucker was limited to 78 games this year because of a fractured right shin, but he hit .289 with 23 homers and 49 RBIs for the AL West champions. New West Virginia coach Rich Rodriguez says leaving for Michigan 17 years ago was a 'mistake' MORGANTOWN, W.Va. (AP) — Rich Rodriguez says he regrets leaving West Virginia 17 years ago. Rodriguez was introduced as the coach at his alma mater on Friday. Based on the welcome he got from the thousands of West Virginia fans in attendance, much seems to be forgiven. Rodriguez told the crowd that he never should have left his home state. The 61-year-old coach says he's grown both as a person and a coach throughout his long career, and that his departure at the end of the 2007 season for a head coaching job at Michigan was a mistake. Rodriguez went 60-26 at West Virginia from 2001 to 2007. Lindsey Vonn to enter World Cup ski races next weekend in Switzerland in her comeback at age 40 BEAVER CREEK, Colo. (AP) — Lindsey Vonn will return to World Cup ski racing next weekend for a pair of super-G events in St. Moritz, Switzerland, as she continues her comeback at 40 years old. Vonn teased her return in an Instagram post through her sponsor, Red Bull, on Friday morning. She said “I hear St. Moritz is pretty nice this time of year.” The U.S. Ski Team then confirmed she will race in St. Moritz. She’s won five of her 82 World Cup races on the venue at St. Moritz. Picabo Street, a two-time Olympic medalist and Vonn’s former teammate, says “it’s the coolest thing ever.” Woman who falsely accused Duke lacrosse players of rape in 2006 publicly admits she lied RALEIGH, N.C. (AP) — The woman who in 2006 falsely accused three Duke University lacrosse players of raping her has admitted publicly for the first time that she made up the story. The accusations made national headlines at the time, stirring tensions about race, class and the privilege of college athletes. Crystal Mangum, who is Black, said in an interview with the “Let’s Talk with Kat” podcast that she “made up a story that wasn’t true” about the white players who attended a party where she was hired to perform as a stripper “because I wanted validation from people and not from God.” The former Duke players were declared innocent in 2007 after Mangum’s story fell apart under legal scrutiny. Belichick's bid to reshape football at UNC another sign of rising pro influence on college level CHAPEL HILL, N.C. (AP) — North Carolina's hiring of NFL coaching great Bill Belichick marks another sign of the growing influence of the NFL on college football. The challenges of managing the transfer portal and looming revenue sharing for athletes has led teams to take on more NFL-like structures to their programs. Belichick is set to structure North Carolina's program like an NFL front office. That includes hiring former NFL executive Michael Lombardi as general manager. At Florida, coach Billy Napier is interviewing general managers while saying the program is going to “a business model” to deal with a “major math puzzle.”

Fifth District Savings Bank ( NASDAQ:FDSB – Get Free Report ) and HSBC ( NYSE:HSBC – Get Free Report ) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. Valuation & Earnings This table compares Fifth District Savings Bank and HSBC”s revenue, earnings per share (EPS) and valuation. HSBC has higher revenue and earnings than Fifth District Savings Bank. Analyst Recommendations Profitability This table compares Fifth District Savings Bank and HSBC’s net margins, return on equity and return on assets. Institutional and Insider Ownership 1.5% of HSBC shares are owned by institutional investors. 0.0% of HSBC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Summary HSBC beats Fifth District Savings Bank on 8 of the 8 factors compared between the two stocks. About Fifth District Savings Bank ( Get Free Report ) Fifth District Bancorp, Inc. is the holding company for Fifth District Savings Bank which provide all banking services. Fifth District Bancorp, Inc. is based in NEW ORLEANS. About HSBC ( Get Free Report ) HSBC Holdings plc provides banking and financial services worldwide. The company operates through Wealth and Personal Banking, Commercial Banking, and Global Banking and Markets segments. The Wealth and Personal Banking segment offers retail banking and wealth products, including current and savings accounts, mortgages and personal loans, credit and debit cards, and local and international payment services; and wealth management services comprising insurance and investment products, global asset management services, investment management, and private wealth solutions. This segment serves personal banking and high net worth individuals. The Commercial Banking segment provides credit and lending, treasury management, payment, cash management, commercial insurance, and investment services; commercial cards; international trade and receivables finance services; foreign exchange products; capital raising services on debt and equity markets; and advisory services. It serves small and medium sized enterprises, mid-market enterprises, and corporates. The Global Banking and Markets segment offers financing, advisory, and transaction services; and credit, rates, foreign exchange, equities, money markets, and securities services; and engages in principal investment activities. It serves government, corporate and institutional clients, and private investors. HSBC Holdings plc was founded in 1865 and is headquartered in London, the United Kingdom. Receive News & Ratings for Fifth District Savings Bank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fifth District Savings Bank and related companies with MarketBeat.com's FREE daily email newsletter .H&M REOPENS ICONIC TIMES SQUARE FLAGSHIP IN NEW YORK CITY AS NEW BRAND SHOWCASEThey were all exceptional – Mikel Arteta loved seeing Arsenal run riot in LisbonNone

John Kirby grilled on mysterious New Jersey drone sightings: 'Why don't we know?'AP Sports SummaryBrief at 6:58 p.m. ESTNone

AbCellera to Present at Upcoming Investor Conferences in December and JanuaryPresident-elect Donald Trump joined the chorus of people raising concerns about mysterious drone sightings over New Jersey and other states on the East Coast, calling on government officials to shoot down the aircraft if they are truly unidentifiable. In a Friday post on his social media platform Truth Social , Trump indicated that he believes authorities know more about the drones than they are letting on. “Mystery Drone sightings all over the Country. Can this really be happening without our government’s knowledge. I don [sic] think so! Let the public know, and now. Otherwise, shot [sic] them down!!! DJT,” the president-elect wrote. Residents of Morris County, New Jersey, first started reporting nighttime sightings of the drones last month. Since then, the FBI and the Department of Homeland Security have investigated the objects and are looking into whether people are seeing actual drones, manned aircraft or something else. “We have no evidence at this time that the reported drone sightings pose a national security or public safety threat or have a foreign nexus,” the FBI and DHS said in a joint statement Thursday. “Upon review of available imagery, it appears that many of the reported sightings are actually manned aircraft, operating lawfully. There are no reported or confirmed drone sightings in any restricted air space.” Nevertheless, reports of drone sightings continued to proliferate on Friday, with even former Maryland Gov. Larry Hogan posting video of what he said were “dozens of large drones” flying over his home on Thursday night. Individuals in New York and Connecticut have also reported seeing the aircraft. Trump’s missive came after White House national security spokesperson John Kirby appeared on Fox News ’ “The Story” on Friday afternoon, where host Martha MacCallum pressed him about whether officials really do not have an explanation for the drone sightings. “I’m not going to lie to you or to the American people, and I’m not going to say we know something when we don’t,” Kirby said. “And we would never, ever stoop to think that an American citizen was crazy or nuts because of what they’re seeing and what they’re documenting. We’re taking that imagery seriously and we’re doing the best we can to analyze it, and we encourage people to come forward if they have additional sightings.” “Why not just take one down and figure out what’s going on?” MacCallum asked. “We don’t have enough conclusions to take that kind of a policy action,” Kirby replied. “But let’s just assume for a minute, Martha, that we did. You’re not going to want to shoot something down where it could hit somebody’s house, or hurt somebody.” Don't let this be the end of the free press. The free press is under attack — and America's future hangs in the balance. As other newsrooms bow to political pressure, HuffPost is not backing down. Would you help us keep our news free for all? We can't do it without you. Can't afford to contribute? Support HuffPost by creating a free account and log in while you read. You've supported HuffPost before, and we'll be honest — we could use your help again . We view our mission to provide free, fair news as critically important in this crucial moment, and we can't do it without you. Whether you give once or many more times, we appreciate your contribution to keeping our journalism free for all. You've supported HuffPost before, and we'll be honest — we could use your help again . We view our mission to provide free, fair news as critically important in this crucial moment, and we can't do it without you. Whether you give just one more time or sign up again to contribute regularly, we appreciate you playing a part in keeping our journalism free for all. Already contributed? Log in to hide these messages. She also asked what President Joe Biden has to say on the issue, and whether Elon Musk or other “outside experts” had been called in to give their opinions. Biden “has tasked the team to look into this and to be energetic in doing it, to try to get answers,” Kirby said. Related From Our PartnerMichael Villella , the actor known for his roles in horror and thriller films such as The Slumber Party Massacre , has died. He was 84. Villella died on Saturday, Nov. 23, after suffering multiple organ failure following several weeks spent in a hospital, his daughter Chloe told TMZ . Further information regarding why he was initially hospitalized was not immediately available. 🤩🤩 SIGN UP for Parade's Trending News newsletter & we'll keep you in the know on the viral pop culture moments & celebrity news everyone is talking about 🗞️🗞️ Villella’s daughter shared a tribute to her father on Facebook following his death. A photo that she posted on the social media platform showed a picture of her late father resting on a countertop beside a lit candle. “May you rest in peace daddy ❤️💋♈️,” she wrote to caption the post, according to a screenshot published by TMZ . Though Villella was known for a handful of characters he played in the 1980s and early 1990s, his most famous role was as serial killer Russ Thorn in 1982’s The Slumber Party Massacre . He also appeared in 1983’s Love Letters , 1988’s Gotham and 1989’s Wild Orchid , among others. Fans of the horror and thriller genres reacted with sadness to the news of Villella’s passing on social media. Several mentioned his role as Thorn as a particularly memorable performance. “Russ Thorn is no doubt one of the scariest slashers who doesn't even need a mask or getup, and that's thanks to Michael's awesomely disturbing portrayal of him. RIP. 💔,” one fan wrote on X , formerly Twitter. Russ Thorn is no doubt one of the scariest slashers who doesn't even need a mask or getup, and that's thanks to Michael's awesomely disturbing portrayal of him. RIP. 💔 “A PHENOMENAL performance,” another fan agreed. “One of the all time greats. To be an iconic slasher villain without a mask or Halloween costume etc is just incredible. Dude was incredible.” “RIP Michael you will be missed you were such an incredible actor and an amazing person!” an X user tweeted. “Damn RIP, Michael. Slumber Party Massacre is one of my favorites 😞,” another fan wrote. Next: Remembering the Stars and Legends We've Lost in 2024

Analysis: Protecting QBs from violent late hits like the one that leveled Trevor Lawrence isn't easy

Some Atlantic City casino workers call on union boss to resign for opposing a smoking ban

LANDOVER, Md. (AP) — Austin Ekeler was concussed in the final minute of the Washington Commanders’ loss to the Dallas Cowboys on Sunday and taken to a hospital for further evaluation. Coach Dan Quinn said he and general manager Adam Peters got to visit with Ekeler before he went to the hospital. A team spokesperson said the decision to transport Ekeler was made out of an abundance of caution. Ekeler, 29, was injured when he was tackled by Damone Clark and Nick Vigil on a kickoff return with 9 seconds left in the fourth quarter. Ekeler remained down on the field for some time being attended to by medical personnel, and players from each team knelt around him with their helmets off. Lineman Andrew Wylie was also concussed and fellow running back Brian Robinson Jr. sprained an ankle in Washington’s third consecutive defeat. Ekeler is in his first season with the Commanders after spending his first nine years in the NFL with the Los Angeles Chargers. AP NFL: https://apnews.com/hub/nflNone

None

Previous: 60 jili
Next: 711 jili casino